IDiyas

For the Inventor, By the Inventor

Thousand Oaks, CA, United States of America

Haoxuan Wang

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 9.8

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Thousand Oaks, CA (US) (2023 - 2024)
  • Somerville, MA (US) (2024)

Company Filing History:

goldMedal8 out of 1,970 
 
Amgen Inc.
 patents
silverMedal7 out of 7 
 
Vigil Neuroscience, Inc.
 patents
bronzeMedal2 out of 1,149 
 
Vertex Pharmaceuticals, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2023-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):
1. 12428425 - Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use (2025-09-30),
2. 12421249 - Inhibitors of APOL1 and methods of using same (2025-09-23),
3. 12319691 - Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use (2025-06-03),
4. 12252489 - Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use (2025-03-18),
5. 12240839 - Cyclobutyl dihydroquinoline sulfonamide compounds (2025-03-04),
6. 11912711 - Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use (2024-02-27),
7. 11884675 - Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use (2024-01-30),
8. 11866446 - Inhibitors of APOL1 and methods of using same (2024-01-09),
9. 11718617 - Heterocyclic compounds as triggering receptor expressed on myeloid cells2 agonists and methods of use (2023-08-08),
10. 11608344 - Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use (2023-03-21),

Title: Haoxuan Wang: Innovator in Neurodegenerative Disorder Treatments

Introduction

Haoxuan Wang is a prominent inventor based in Thousand Oaks, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurodegenerative disorders and APOL1-mediated diseases. With a total of 10 patents to his name, Wang's work is at the forefront of medical innovation.

Latest Patents

Wang's latest patents include groundbreaking research on heterocyclic compounds that act as agonists for the Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). This patent outlines compounds that can activate TREM2, which is crucial for potential treatments of neurodegenerative disorders. Additionally, he has developed inhibitors of APOL1, which are aimed at treating diseases such as pancreatic cancer and focal segmental glomerulosclerosis (FSGS). These patents not only provide new therapeutic avenues but also include methods for synthesizing these important compounds.

Career Highlights

Throughout his career, Haoxuan Wang has worked with notable companies in the biotechnology sector, including Amgen Inc. and Vigil Neuroscience, Inc. His experience in these organizations has allowed him to collaborate on innovative projects that push the boundaries of current medical treatments.

Collaborations

Wang has collaborated with talented professionals in his field, including Lara C Czabaniuk and Timothy Hopper. These partnerships have contributed to the successful development of his patented technologies and have enhanced the impact of his work in the industry.

Conclusion

Haoxuan Wang is a distinguished inventor whose work in pharmaceuticals is paving the way for new treatments for serious medical conditions. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…